The 140th Annual Meeting of the Pharmaceutical Society of Japan (Kyoto)

Presentation information

Print

Oral Presentation

(E) Biopharmaceutics

[26L-am] 薬物治療（がん）

Thu. Mar 26, 2020 9:00 AM - 11:24 AM [Room L] Room C-1 (1F)

Chair: Kenichi Fujita, Hiromi Ii

9:36 AM - 9:48 AM

[26L-am04] Bevacizumab increase endothelin-1 secretion by inhibition of VEGF-A signaling in renal glomeruli endothelial cells

○Sator Nihei1,2, takeshi chiba3, tomohiko tairabune1,2, kenzo kudo1,2 (1. Department of Clinical Pharmaceutics and Pharmacy Practice, School of Pharmacy, Iwate Medical University , 2. Department of Pharmacy, Iwate Medical University Hospital, 3. Hokkaido Pharmaceutical University School of Pharmacy)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Password